{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:06:55Z","timestamp":1761523615209},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12032-009-9374-x","type":"journal-article","created":{"date-parts":[[2009,11,30]],"date-time":"2009-11-30T17:05:25Z","timestamp":1259600725000},"page":"1277-1285","source":"Crossref","is-referenced-by-count":25,"title":["The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Seung Tae","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Oh","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Yeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Ki","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Kyung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poong-Lyul","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Shick","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haeran","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Beom","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hyeon","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Kyung","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,1]]},"reference":[{"key":"9374_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jso.20156","volume":"88","author":"P Gervaz","year":"2004","unstructured":"Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol. 2004;88:261\u20136.","journal-title":"J Surg Oncol"},{"key":"9374_CR2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1067\/msy.2002.119816","volume":"131","author":"P Gervaz","year":"2002","unstructured":"Gervaz P, et al. Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer. Surgery. 2002;131:190\u20137.","journal-title":"Surgery"},{"key":"9374_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1470-2045(02)00649-6","volume":"3","author":"AM Haydon","year":"2002","unstructured":"Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol. 2002;3:83\u20138.","journal-title":"Lancet Oncol"},{"key":"9374_CR4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/gast.2002.35392","volume":"123","author":"JR Jass","year":"2002","unstructured":"Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862\u201376.","journal-title":"Gastroenterology"},{"key":"9374_CR5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.8484121","volume":"260","author":"LA Aaltonen","year":"1993","unstructured":"Aaltonen LA, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812\u20136.","journal-title":"Science"},{"key":"9374_CR6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/363558a0","volume":"363","author":"Y Ionov","year":"1993","unstructured":"Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993;363:558\u201361.","journal-title":"Nature"},{"key":"9374_CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/bjs.5328","volume":"93","author":"K Soreide","year":"2006","unstructured":"Soreide K, Janssen EA, Soiland H, Korner H, Baak JP. Microsatellite instability in colorectal cancer. Br J Surg. 2006;93:395\u2013406.","journal-title":"Br J Surg"},{"key":"9374_CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1542-3565(03)00314-8","volume":"2","author":"Y Miyakura","year":"2004","unstructured":"Miyakura Y, et al. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol. 2004;2:147\u201356.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9374_CR9","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349:2042\u201354.","journal-title":"N Engl J Med"},{"key":"9374_CR10","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","volume":"95","author":"JG Herman","year":"1998","unstructured":"Herman JG, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA. 1998;95:6870\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9374_CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gut.42.5.673","volume":"42","author":"JR Jass","year":"1998","unstructured":"Jass JR, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998;42:673\u20139.","journal-title":"Gut"},{"key":"9374_CR12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.8484122","volume":"260","author":"SN Thibodeau","year":"1993","unstructured":"Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260:816\u20139.","journal-title":"Science"},{"key":"9374_CR13","first-page":"5849","volume":"53","author":"RA Lothe","year":"1993","unstructured":"Lothe RA, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 1993;53:5849\u201352.","journal-title":"Cancer Res"},{"key":"9374_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","volume":"342","author":"R Gryfe","year":"2000","unstructured":"Gryfe R, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69\u201377.","journal-title":"N Engl J Med"},{"key":"9374_CR15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","volume":"23","author":"S Popat","year":"2005","unstructured":"Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609\u201318.","journal-title":"J Clin Oncol"},{"key":"9374_CR16","first-page":"1374","volume":"56","author":"DA Anthoney","year":"1996","unstructured":"Anthoney DA, McIlwrath AJ, Gallagher WM, Edlin AR, Brown R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 1996;56:1374\u201381.","journal-title":"Cancer Res"},{"key":"9374_CR17","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1074\/jbc.275.6.3922","volume":"275","author":"S Gradia","year":"2000","unstructured":"Gradia S, Acharya S, Fishel R. The role of mismatched nucleotides in activating the hMSH2-hMSH6 molecular switch. J Biol Chem. 2000;275:3922\u201330.","journal-title":"J Biol Chem"},{"key":"9374_CR18","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1073\/pnas.90.14.6424","volume":"90","author":"A Kat","year":"1993","unstructured":"Kat A, et al. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci USA. 1993;90:6424\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9374_CR19","first-page":"3087","volume":"56","author":"S Aebi","year":"1996","unstructured":"Aebi S, et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 1996;56:3087\u201390.","journal-title":"Cancer Res"},{"key":"9374_CR20","first-page":"4881","volume":"56","author":"D Fink","year":"1996","unstructured":"Fink D, et al. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 1996;56:4881\u20136.","journal-title":"Cancer Res"},{"key":"9374_CR21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic CM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247\u201357.","journal-title":"N Engl J Med"},{"key":"9374_CR22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.2006.05.8172","volume":"25","author":"GP Kim","year":"2007","unstructured":"Kim GP, et al. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a national cancer institute-national surgical adjuvant breast and bowel project collaborative study. J Clin Oncol. 2007;25:767\u201372.","journal-title":"J Clin Oncol"},{"key":"9374_CR23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0140-6736(02)11402-4","volume":"360","author":"PL Barratt","year":"2002","unstructured":"Barratt PL, et al. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet. 2002;360:1381\u201391.","journal-title":"Lancet"},{"key":"9374_CR24","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2006.09.8467","volume":"25","author":"E Diaz-Rubio","year":"2007","unstructured":"Diaz-Rubio E, et al. Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial. J Clin Oncol. 2007;25:4224\u201330.","journal-title":"J Clin Oncol"},{"key":"9374_CR25","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1200\/JCO.2005.17.749","volume":"23","author":"H Kelly","year":"2005","unstructured":"Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol. 2005;23:4553\u201360.","journal-title":"J Clin Oncol"},{"key":"9374_CR26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra040958","volume":"352","author":"JA Meyerhardt","year":"2005","unstructured":"Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476\u201387.","journal-title":"N Engl J Med"},{"key":"9374_CR27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00384-008-0504-2","volume":"23","author":"CI Muller","year":"2008","unstructured":"Muller CI, et al. Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO colorectal study group. Int J Colorectal Dis. 2008;23:1033\u20139.","journal-title":"Int J Colorectal Dis"},{"key":"9374_CR28","first-page":"1615","volume":"29","author":"G Des Guetz","year":"2009","unstructured":"Des Guetz G, et al. Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis. Anticancer Res. 2009;29:1615\u201320.","journal-title":"Anticancer Res"},{"key":"9374_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11523-008-0103-8","volume":"4","author":"G Des Guetz","year":"2009","unstructured":"Des Guetz G, Uzzan B, Nicolas P, Schischmanoff O, Morere JF. Microsatellite instability: a predictive marker in metastatic colorectal cancer? Target Oncol. 2009;4:57\u201362.","journal-title":"Target Oncol"},{"key":"9374_CR30","first-page":"2715","volume":"27","author":"G des Guetz","year":"2007","unstructured":"des Guetz G, et al. Microsatellite instability and sensitivity to FOLFOX treatment in metastatic colorectal cancer. Anticancer Res. 2007;27:2715\u20139.","journal-title":"Anticancer Res"},{"key":"9374_CR31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6604867","volume":"100","author":"M Koopman","year":"2009","unstructured":"Koopman M, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100:266\u201373.","journal-title":"Br J Cancer"},{"key":"9374_CR32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3816\/CCC.2007.n.012","volume":"6","author":"LH Jensen","year":"2007","unstructured":"Jensen LH, Danenberg KD, Danenberg PV, Jakobsen A. Predictive value of MSH2 gene expression in colorectal cancer treated with capecitabine. Clin Colorectal Cancer. 2007;6:433\u20135.","journal-title":"Clin Colorectal Cancer"},{"key":"9374_CR33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3904\/kjim.2005.20.2.116","volume":"20","author":"WH Choe","year":"2005","unstructured":"Choe WH, et al. High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients. Korean J Intern Med. 2005;20:116\u201322.","journal-title":"Korean J Intern Med"},{"key":"9374_CR34","first-page":"3579","volume":"58","author":"A Vaisman","year":"1998","unstructured":"Vaisman A, et al. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 1998;58:3579\u201385.","journal-title":"Cancer Res"},{"key":"9374_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.onc.1201167","volume":"15","author":"R Brown","year":"1997","unstructured":"Brown R, et al. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. Oncogene. 1997;15:45\u201352.","journal-title":"Oncogene"},{"key":"9374_CR36","first-page":"6039","volume":"60","author":"JA Plumb","year":"2000","unstructured":"Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown R. Reversal of drug resistance in human tumor xenografts by 2\u2019-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res. 2000;60:6039\u201344.","journal-title":"Cancer Res"},{"key":"9374_CR37","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/sj.onc.1202540","volume":"18","author":"G Strathdee","year":"1999","unstructured":"Strathdee G, MacKean MJ, Illand M, Brown R. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene. 1999;18:2335\u201341.","journal-title":"Oncogene"},{"key":"9374_CR38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)64059-X","volume":"158","author":"G Strathdee","year":"2001","unstructured":"Strathdee G, et al. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol. 2001;158:1121\u20137.","journal-title":"Am J Pathol"},{"key":"9374_CR39","first-page":"1841","volume":"57","author":"D Fink","year":"1997","unstructured":"Fink D, et al. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 1997;57:1841\u20135.","journal-title":"Cancer Res"},{"key":"9374_CR40","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.gastro.2008.06.033","volume":"135","author":"ES Schernhammer","year":"2008","unstructured":"Schernhammer ES, Ogino S, Fuchs CS. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology. 2008;135:770\u201380.","journal-title":"Gastroenterology"},{"key":"9374_CR41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjc.6602358","volume":"92","author":"AJ Munro","year":"2005","unstructured":"Munro AJ, Lain S, Lane DP. P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer. 2005;92:434\u201344.","journal-title":"Br J Cancer"},{"key":"9374_CR42","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.bjc.6603728","volume":"96","author":"O Nehls","year":"2007","unstructured":"Nehls O, et al. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer. 2007;96:1409\u201318.","journal-title":"Br J Cancer"},{"key":"9374_CR43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1200\/JCO.2002.07.080","volume":"20","author":"CJ Allegra","year":"2002","unstructured":"Allegra CJ, et al. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. J Clin Oncol. 2002;20:1735\u201343.","journal-title":"J Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9374-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9374-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:42Z","timestamp":1559442162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9374"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9374-x","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,1]]}}}